Minutes of Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation meeting, 26 February 1998, re Hepatitis C cases, virally inactivated plasma, NAT implementation, leucodepletion, informing patients who had received nvCJD implicated blood/blood products, record-keeping for patients who had received blood/blood products, autologous transfusion, progress report on nvCJD, blood transfusion implications of proposed UK and European preventative measures, update on study of CJD surveillance and blood services, CMOs work on blood transfusion practice, HTLV1, Hepatitis G proposal from the PHLS. Chairman Dr J.S. Metters. Present Dr A.J. Cant, Dr D.W. Gorst, Dr D.B.L. McClelland, Dr P. Mortimer, Dr E.A. Robinson, Dr T.J. Snape, Dr T. Wyatt, Dr R.E. Warren, Professor H. Thomas, P. Comer, Dr L. Williamson. Observers Dr A. Mairs, Dr W. Smith, Dr A. Keel, Dr Doyle, Dr Nicholas, Dr Tsang, Dr Wingfield, J. Dhell. Secretariat Dr M. McGovern, G. Skinner, T. McHugh. Ref MSBT 14/12